Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00033397 · ClinicalTrials.gov registry record

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
360
Enrollment target

NCT00033397 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 360 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00033397 has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
360 participants
Enrollment target

Study Summary

RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.

Interventions

  • PROCEDURE biopsy
  • PROCEDURE magnetic resonance imaging
  • PROCEDURE ultrasound imaging
  • PROCEDURE radiomammography
  • RADIATION gadopentetate dimeglumine

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2002-02
Est. Completion 2012-05-01

What the Registry Record Tells You About NCT00033397

The ClinicalTrials.gov registry entry for NCT00033397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which biopsy is the first listed.

NCT00033397 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00033397 about?

NCT00033397 is a clinical study titled "Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery". RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women w...

What is the current status of trial NCT00033397?

This trial is currently completed. The enrollment target is 360 participants. The study started on 2002-02. Estimated completion is 2012-05-01.

What interventions are being tested in trial NCT00033397?

The interventions under investigation include: biopsy (PROCEDURE), magnetic resonance imaging (PROCEDURE), ultrasound imaging (PROCEDURE), radiomammography (PROCEDURE), gadopentetate dimeglumine (RADIATION).

Who is sponsoring clinical trial NCT00033397?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.